Transonic Systems, Inc. appears in the linked FDA record as the applicant for a single premarket notification, K261714, received 26 May 2026 and decided 27 October 2026 with decision code SESE, described as Substantially Equivalent. The submission covers the FlowXL® System: FlowXL Flowmeter and compatible Flowprobes and Flowsensors, filed as a Traditional 510(k) with a Summary, under product code DPW and regulation number 870.2100, device class 2, in the cardiovascular advisory committee. The filing address is in Ithaca, New York. Company-published material describes FlowXL as a standalone touchscreen flowmeter used during surgery with Transonic Flowprobes to measure, display and document absolute volume flow in vessels and other derived parameters. [1][2][5]
The cleared submission and its scope
K261714 is the only linked record in the supplied collection, and its decision count is one SESE. The record identifies the device as the FlowXL® System: FlowXL Flowmeter and compatible Flowprobes and Flowsensors, with product code DPW, regulation number 870.2100, device class 2, advisory committee CV, and a Traditional clearance type with no third-party review. The decision description reads Substantially Equivalent. The sample is a snapshot of supplied filings, not a measure of total company portfolio, sales or safety performance. [1][2]
The FDA record lists the applicant as Transonic Systems, Inc. at 34 Dutch Mill Rd., Ithaca, NY 14850, with country code US. That address is the filing address in the record and is not treated here as a verified headquarters. The record does not identify a parent company, brand owner or corporate structure, and none is asserted. [1][7]
Documented FlowXL components
Transonic's FlowXL Flowprobe document describes HS-Series intraoperative perivascular Flowprobes that work with the HT520 Series FlowXL Flowmeter to measure instantaneous and average volume flow in blood vessels or grafts, 0.5 mm to 36 mm. Probe model numbers indicate the compatible meter, probe size, and probe style, with styles listed as FMC, FMV, MU and others. The same document describes a range of intraoperative perivascular Flowprobes and extracorporeal clamp-on tubing Flowsensors. [3]
A separate specifications sheet lists HS clinical Flowprobe models as AU, FMC, FME, FMV, MB/MR, MBS/MRS and MU, and states that a suffix on the catalog number represents the number of uses for that item. The FlowXL meter document describes a 12.1-inch color capacitive touchscreen, two flowsensor connectors, USB ports, a DVI-D port for a secondary display, an auxiliary input for ECG, and an Ethernet port not active on initial release. [5][7]
Published configuration and software options
Transonic's build-your-meter page presents FlowXL as a configurable system with choices of software, mount and printing option. It describes Quickflow and AdvancedFlow software, snapshot capture with export and print capability, and no patient data entry or memory. It also lists an integrated cart with printer shelf and a drawer for storage. These are company-published descriptions of configuration options, not verified commercial availability. [4]
The FlowXL meter document states that the device is a standalone touchscreen flowmeter used during surgery with Transonic Flowprobes, that it is configurable, and that it is available in Europe. It lists compliance with IEC60601-1 and CE marking per 93/42/EEC Annex II as amended by Directive 2007/47/EEC, and names an HP Deskjet 3760 printer for use in Europe. [5]
Company context as published
Transonic's own site states that clinicians, researchers and medical device developers turn to Transonic for measurement solutions, and that its measurements have been associated with gold-standard clinical and research measurement tools for over three decades. It also describes clamp-on and precision inline Flowsensors for tubing flow measurement. These are company statements about its technology and history, not independently verified findings. [6]
The probe specifications sheet lists contact locations for Transonic Systems Inc. in Ithaca, New York, Transonic Europe B.V. in Elsloo, the Netherlands, Transonic Asia Inc. in Taoyuan, Taiwan, and Nipro-Transonic Japan Inc. in Tokyo. The Flowprobe document also lists an Australia distributor, Qualtech Consulting Corp. PTY LTD in Sydney. These are published contact and distribution listings; ownership relationships beyond the names shown are not established by the public documents. [3][7]

